674 related articles for article (PubMed ID: 26365159)
1. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
Luan H; Liu LF; Tang Z; Zhang M; Chua KK; Song JX; Mok VC; Li M; Cai Z
Sci Rep; 2015 Sep; 5():13888. PubMed ID: 26365159
[TBL] [Abstract][Full Text] [Related]
2. LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
Luan H; Liu LF; Meng N; Tang Z; Chua KK; Chen LL; Song JX; Mok VC; Xie LX; Li M; Cai Z
J Proteome Res; 2015 Jan; 14(1):467-78. PubMed ID: 25271123
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.
Hatano T; Saiki S; Okuzumi A; Mohney RP; Hattori N
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):295-301. PubMed ID: 25795009
[TBL] [Abstract][Full Text] [Related]
5. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
Zhao H; Wang C; Zhao N; Li W; Yang Z; Liu X; Le W; Zhang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():101-108. PubMed ID: 29518718
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
7. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
8. A metabolomic signature of treated and drug-naïve patients with Parkinson's disease: a pilot study.
Troisi J; Landolfi A; Vitale C; Longo K; Cozzolino A; Squillante M; Savanelli MC; Barone P; Amboni M
Metabolomics; 2019 Jun; 15(6):90. PubMed ID: 31183578
[TBL] [Abstract][Full Text] [Related]
9. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential urine biomarkers in idiopathic parkinson's disease using NMR.
Kumari S; Kumaran SS; Goyal V; Sharma RK; Sinha N; Dwivedi SN; Srivastava AK; Jagannathan NR
Clin Chim Acta; 2020 Nov; 510():442-449. PubMed ID: 32791135
[TBL] [Abstract][Full Text] [Related]
11. Exploratory investigation of plasma metabolomics in human lung adenocarcinoma.
Wen T; Gao L; Wen Z; Wu C; Tan CS; Toh WZ; Ong CN
Mol Biosyst; 2013 Sep; 9(9):2370-8. PubMed ID: 23857124
[TBL] [Abstract][Full Text] [Related]
12. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
Kumar BS; Chung BC; Kwon OS; Jung BH
J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
[TBL] [Abstract][Full Text] [Related]
13. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry.
Dittharot K; Jittorntam P; Wilairat P; Sobhonslidsuk A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):741-748. PubMed ID: 29582629
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
15. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
16. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
[TBL] [Abstract][Full Text] [Related]
17. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
18. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
Yan B; Huang J; Dong F; Yang L; Huang C; Gao M; Shi A; Zha W; Shi L; Hu X
Biomed Chromatogr; 2016 Nov; 30(11):1877-1881. PubMed ID: 27061577
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic biomarkers as strong correlates of Parkinson disease progression.
LeWitt PA; Li J; Lu M; Guo L; Auinger P;
Neurology; 2017 Feb; 88(9):862-869. PubMed ID: 28179471
[TBL] [Abstract][Full Text] [Related]
20. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
Zhang L; Li L; Kong H; Zeng F
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]